Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Basic & Clinical Pharmacology & Toxicology|June 22, 2010
Frequencies of single-nucleotide polymorphisms of SLCO1A2, SLCO1B3 and SLCO2B1 genes in a Finnish populationAlli Laitinen, Mikko NiemiOncology|May 21, 2020
Transketolase-Like Protein 1 and Glucose Transporter 1 in Gastric CancerKaisa Ahopelto, Alli Laitinen, Jaana Hagström, et al.Scientific Reports|August 31, 2019
Evaluation of toll-like receptors as prognostic biomarkers in gastric cancer: high tissue TLR5 predicts a better outcomeAaro Kasurinen, Jaana Hagström, Alli Laitinen, et al.Plos One|August 31, 2017
High PROX1 expression in gastric cancer predicts better survivalAlli Laitinen, Camilla Böckelman, Jaana Hagström, et al.Acta Oncologica (Stockholm, Sweden)|March 4, 2020
Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancerAaro Kasurinen, Alli Laitinen, Arto Kokkola, et al.Plos One|December 12, 2018
High serum MMP-14 predicts worse survival in gastric cancerAaro Kasurinen, Taina Tervahartiala, Alli Laitinen, et al.Plos One|December 18, 2015
Podocalyxin as a Prognostic Marker in Gastric CancerAlli Laitinen, Camilla Böckelman, Jaana Hagström, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 8, 2018
Serum MMP-8 and TIMP-1 as prognostic biomarkers in gastric cancerAlli Laitinen, Jaana Hagström, Harri Mustonen, et al.Plos One|February 24, 2018
Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosisLeena Arpalahti, Alli Laitinen, Jaana Hagström, et al.Cancer Medicine|September 28, 2019
High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1Aaro Kasurinen, Silvia Gramolelli, Jaana Hagström, et al.Pageof 1